Vulnerability Monitor

The vendors, products, and vulnerabilities you care about

CVE-2018-14786

Becton, Dickinson and Company (BD) Alaris Plus medical syringe pumps (models Alaris GS, Alaris GH, Alaris CC, and Alaris TIVA) versions 2.3.6 and prior are affected by an improper authentication vulnerability where the software does not perform authentication for functionality that requires a provable user identity, where it may allow a remote attacker to gain unauthorized access to various Alaris Syringe pumps and impact the intended operation of the pump when it is connected to a terminal server via the serial port.

Security Impact Summary

This vulnerability carries a CRITICAL severity rating with a CVSS v3.1 score of 9.4, indicating it can be exploited remotely over the network with relatively low complexity without requiring user interaction and does not require pre-existing privileges . The vulnerability impacts limited data confidentiality, integrity (unauthorized modifications), and availability (service disruption) for affected systems. Impacting 8 products from bd, from bd, from bd and 5 others, organizations running these solutions should prioritize assessment and patching.

Historical Context

First disclosed in 2018, this vulnerability was reported during a period defined by widespread IoT adoption challenges, mobile security concerns, and the emergence of advanced persistent threat (APT) techniques. Contemporary mitigation strategies focused on secure development practices and third-party component vetting.

Published

2018-08-23T19:29:00.800

Last Modified

2024-11-21T03:49:47.413

Status

Modified

Source

[email protected]

Severity

CVSSv3.0: 9.4 (CRITICAL)

CVSSv2 Vector

AV:N/AC:L/Au:N/C:P/I:P/A:P

Access Vector: NETWORK
Access Complexity: LOW
Authentication: NONE
Confidentiality Impact: PARTIAL
Integrity Impact: PARTIAL
Availability Impact: PARTIAL

Exploitability Score

10.0

Impact Score

6.4

Weaknesses

Type: Secondary
CWE-287
Type: Primary
CWE-287

Affected Vendors & Products

Type	Vendor	Product	Version/Range	Vulnerable?
Operating System	bd	alaris_gs_firmware	≤ 2.3.6	Yes
Hardware	bd	alaris_gs	-	No
Operating System	bd	alaris_gh_firmware	≤ 2.3.6	Yes
Hardware	bd	alaris_gh	-	No
Operating System	bd	alaris_cc_firmware	≤ 2.3.6	Yes
Hardware	bd	alaris_cc	-	No
Operating System	bd	alaris_tiva_firmware	≤ 2.3.6	Yes
Hardware	bd	alaris_tiva	-	No

References

http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states Vendor Advisory ([email protected])
http://www.securityfocus.com/bid/105147 Third Party Advisory, VDB Entry ([email protected])
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 Third Party Advisory, US Government Resource ([email protected])
http://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-for-various-alaris-plus-syringe-pumps-sold-and-in-use-outside-the-united-states Vendor Advisory (af854a3a-2127-422b-91ae-364da2661108)
http://www.securityfocus.com/bid/105147 Third Party Advisory, VDB Entry (af854a3a-2127-422b-91ae-364da2661108)
https://ics-cert.us-cert.gov/advisories/ICSMA-18-235-01 Third Party Advisory, US Government Resource (af854a3a-2127-422b-91ae-364da2661108)

How SecUtils Interprets This CVE

SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For bd's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.